{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:00:49Z","timestamp":1781632849348,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharm Health Care Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pentamidine is an alternative treatment for Pneumocystis pneumonia (PCP) in patients who are intolerant to sulfamethoxazole-trimethoprim; however, its use is limited by serious adverse effects, including glycemic fluctuations. Herein, we report a case in which intermittently scanned continuous glucose monitoring (isCGM) was used to monitor real-time glycemic fluctuations during pentamidine therapy, enabling successful completion of treatment. To contextualize this case, we also conducted a targeted literature review of pentamidine-induced glucose dysregulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>An 86-year-old Japanese man undergoing immunosuppressive therapy for rheumatoid arthritis was diagnosed with PCP and initially treated with sulfamethoxazole-trimethoprim. Because of suspected adverse effects of sulfamethoxazole-trimethoprim, the patient was switched to intravenous pentamidine as second-line therapy. Given the risks associated with advanced age, abnormal kidney function, and concomitant use of clopidogrel, an organic cation transporter 1 (OCT1) inhibitor that may affect pentamidine disposition, glycemic monitoring was initiated using isCGM. The patient experienced nocturnal hypoglycemia soon after initiating pentamidine treatment, which persisted after pentamidine discontinuation. He subsequently developed marked hyperglycemia associated with impaired endogenous insulin secretion, necessitating temporary regular insulin administration and sitagliptin combination therapy. His glycemic control gradually stabilized, and recovery of pancreatic \u03b2-cell function was confirmed by increased urinary C-peptide levels. In a literature review of 83 reports published between 1995 and 2025, only nine cases of pentamidine-associated dysglycemia were identified, and this was the only case that demonstrated biphasic glucose dysregulation with both hypoglycemia and hyperglycemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case demonstrates that biphasic glucose dysregulation associated with pentamidine (early hypoglycemia followed by delayed-onset hyperglycemia) can be captured using isCGM. Real-time glucose monitoring during pentamidine therapy enabled early intervention and safe completion of treatment. Glycemic monitoring using isCGM may be beneficial in patients receiving pentamidine, especially those with abnormal kidney function, older patients, or those receiving concomitant OCT1 inhibitor therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40780-026-00549-3","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:56:10Z","timestamp":1770458170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Biphasic dysglycemia induced by pentamidine and detected by intermittently scanned continuous glucose monitoring: a case report of a possible drug-drug interaction with clopidogrel and literature review"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0235-7615","authenticated-orcid":false,"given":"Yuki","family":"Nakano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Kuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rintaro","family":"Sogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisanari","family":"Yasukochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Okayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misato","family":"Motoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiro","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Hasuwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisato","family":"Shimanoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"key":"549_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1021\/jm00214a014","volume":"20","author":"BP Das","year":"1977","unstructured":"Das BP, Boykin DW. Synthesis and antiprotozoal activity of 2, 5-bis(4-guanylphenyl)furans. J Med Chem. 1977;20:531\u201336.","journal-title":"J Med Chem"},{"key":"549_CR2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1128\/AAC.24.5.674","volume":"24","author":"LL Pifer","year":"1983","unstructured":"Pifer LL, Pifer DD, Woods DR. Biological profile and response to anti-Pneumocystis agents of Pneumocystis carinii in cell culture. Antimicrob Agents Chemother. 1983;24:674\u201378.","journal-title":"Antimicrob Agents Chemother"},{"key":"549_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s13054-018-2221-8","volume":"22","author":"JJ Schmidt","year":"2018","unstructured":"Schmidt JJ, Lueck C, Ziesing S, Stoll M, Haller H, Gottlieb J, et al. Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years. Crit Care. 2018;22:307.","journal-title":"Crit Care"},{"key":"549_CR4","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.jiac.2021.07.011","volume":"27","author":"T Hirai","year":"2021","unstructured":"Hirai T, Yamaga R, Ishikawa Y, Hanada K, Iwamoto T, Itoh T. Effect of high-dose sulfamethoxazole\/trimethoprim and glucocorticoid use on hyperkalemic event: a retrospective observational study. J Infect Chemother. 2021;27:1607\u201313.","journal-title":"J Infect Chemother"},{"key":"549_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40780-022-00251-0","volume":"8","author":"Y Shimizu","year":"2022","unstructured":"Shimizu Y, Hirai T, Ogawa Y, Yamada C, Kobayashi E. Characteristics of risk factors for acute kidney injury among inpatients administered sulfamethoxazole\/trimethoprim: a retrospective observational study. J Pharm Health Care Sci. 2022;8:20.","journal-title":"J Pharm Health Care Sci"},{"key":"549_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.phrs.2018.06.010","volume":"134","author":"S Brakemeier","year":"2018","unstructured":"Brakemeier S, Pfau A, Zukunft B, Budde K, Nickel P. Prophylaxis and treatment of Pneumocystis jirovecii pneumonia after solid organ transplantation. Pharmacol Res. 2018;134:61\u201367.","journal-title":"Pharmacol Res"},{"key":"549_CR7","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/clinids\/24.5.854","volume":"24","author":"JG O\u2019Brien","year":"1997","unstructured":"O\u2019Brien JG, Dong BJ, Coleman RL, Gee L, Balano KB. A 5-year retrospective review of adverse drug reactions and their risk factors in human immunodeficiency virus-infected patients who were receiving intravenous pentamidine therapy for Pneumocystis carinii pneumonia. Clin Infect Dis. 1997;24:854\u201359.","journal-title":"Clin Infect Dis"},{"key":"549_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0002-9343(84)90433-9","volume":"77","author":"K Osei","year":"1984","unstructured":"Osei K, Falko JM, Nelson KP, Stephens R. Diabetogenic effect of pentamidine. In vitro and in vivo studies in a patient with malignant insulinoma. Am J Med. 1984;77:41\u201346.","journal-title":"Am J Med"},{"key":"549_CR9","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.2337\/dc18-1150","volume":"41","author":"SV Edelman","year":"2018","unstructured":"Edelman SV, Argento NB, Pettus J, Hirsch IB. Clinical implications of real-time and intermittently scanned continuous glucose monitoring. Diabetes Care. 2018;41:2265\u201374.","journal-title":"Diabetes Care"},{"key":"549_CR10","first-page":"24","volume":"14","author":"P Adolfsson","year":"2018","unstructured":"Adolfsson P, Parkin CG, Thomas A, Krinelke LG. Selecting the appropriate continuous glucose monitoring system - a practical approach. Eur Endocrinol. 2018;14:24\u201329.","journal-title":"Eur Endocrinol"},{"key":"549_CR11","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA, 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","DOI":"10.1136\/bmj.n71"},{"key":"549_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1177\/0956462418795580","volume":"30","author":"M Okazaki","year":"2019","unstructured":"Okazaki M, Okazaki M, Nakamura M, Asagiri T, Takeuchi S. Consecutive hypoglycemia attacks induced by co-trimoxazole followed by pentamidine in a patient with acquired immunodeficiency syndrome. Int J STD AIDS. 2019;30:86\u201389.","journal-title":"Int J STD AIDS"},{"key":"549_CR13","first-page":"769","volume":"62","author":"K Hayakawa","year":"2019","unstructured":"Hayakawa K, Nakano Y, Yoshimatsu H, Yamanishi K, Hayakawa T, Yamanishi H, et al. A case of nocturnal hypoglycemia due to pentamidine detected by continuous glucose monitoring. J Jpn Diab Soc. 2019;62:769\u201373.","journal-title":"J Jpn Diab Soc"},{"key":"549_CR14","first-page":"4","volume":"67","author":"K Tomishima","year":"2013","unstructured":"Tomishima K, Kunimasa J, Arima N, Kobayashi M. A case of AIDS patient who had developed pentamidine-induced hypoglycemia and recovered from it two months later. J Jpn Natl Med Serv. 2013;67:4\u20137.","journal-title":"J Jpn Natl Med Serv"},{"key":"549_CR15","doi-asserted-by":"crossref","unstructured":"Herrmann BL, Saller B, Sauer J, Brockmeyer N, Mann K. 26-year-old patient with cutaneous leishmaniasis and an initial diabetes mellitus manifestation. In: Internist (Berl). 1999;40:561\u2013564. German.","DOI":"10.1007\/s001080050370"},{"key":"549_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/1056-8727(95)00111-5","volume":"11","author":"E Ubukata","year":"1997","unstructured":"Ubukata E, Mokuda O, Nagata M, Ogino Y, Sakamoto Y, Tanaka K, et al. A pentamidine-treated acquired immunodeficiency syndrome patient associated with sudden onset diabetes mellitus and high tumor necrosis factor alpha level. J Diabetes Complications. 1997;11:256\u201358.","journal-title":"J Diabetes Complications"},{"key":"549_CR17","unstructured":"Pae Y, Koyanagi S, Sawayama Y, Tani Y, Hayashi J, Kashiwagi S. An AIDS case of probable pentamidine-induced diabetic ketoacidosis and severe acute pancreatitis. In: Nihon Shokakibyo Gakkai Zasshi. 1996;93:226\u2013230. Japanese."},{"key":"549_CR18","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/clinids\/23.4.845","volume":"23","author":"V Abril","year":"1996","unstructured":"Abril V, Ortega E, Segarra P, Pedro F, Sabater V, Herrera A. Rhinocerebral mucormycosis in a patient with AIDS: a complication of diabetic ketoacidosis following pentamidine therapy. Clin Infect Dis. 1996;23:845\u201346.","journal-title":"Clin Infect Dis"},{"key":"549_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/00006676-199510000-00016","volume":"11","author":"CP Lu","year":"1995","unstructured":"Lu CP, Wu HP, Chuang LM, Lin BJ, Chuang CY, Tai TY. Pentamidine-induced hyperglycemia and ketosis in acquired immunodeficiency syndrome. Pancreas. 1995;11:315\u201316.","journal-title":"Pancreas"},{"key":"549_CR20","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1001\/archinte.1995.00430060109019","volume":"155","author":"G Nasti","year":"1995","unstructured":"Nasti G, Zanette G, Inchiostro S, Donadon V, Tirelli U. Diabetes mellitus following intravenous pentamidine administration in a patient with HIV infection. Arch Intern Med. 1995;155:645\u201346.","journal-title":"Arch Intern Med"},{"key":"549_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2337\/diab.31.1.40","volume":"31","author":"P Bouchard","year":"1982","unstructured":"Bouchard P, Sai P, Reach G, Caubarrere I, Ganeval D, Assan R. Diabetes mellitus following pentamidine-induced hypoglycemia in humans. Diabetes. 1982;31:40\u201345.","journal-title":"Diabetes"},{"key":"549_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2337\/diacare.18.1.47","volume":"18","author":"R Assan","year":"1995","unstructured":"Assan R, Perronne C, Assan D, Chotard L, Mayaud C, Matheron S, et al. Pentamidine-induced derangements of glucose homeostasis. Determinant roles of renal failure and drug accumulation. A study of 128 patients. Diabetes Care. 1995;18:47\u201355.","journal-title":"Diabetes Care"},{"key":"549_CR23","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.4239\/wjd.v6.i8.1073","volume":"6","author":"HE Tamez-Perez","year":"2015","unstructured":"Tamez-Perez HE, Quintanilla-Flores DL, Rodriguez-Gutierrez R, Gonzalez-Gonzalez JG, Tamez-Pena AL. Steroid hyperglycemia: prevalence, early detection and therapeutic recommendations: a narrative review. World J Diabetes. 2015;6:1073\u201381.","journal-title":"World J Diabetes"},{"key":"549_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/bdd.643","volume":"30","author":"JY Jin","year":"2009","unstructured":"Jin JY, Jusko WJ. Pharmacodynamics of glucose regulation by methylprednisolone. I. Adrenalectomized Rats. Biopharm Drug Dispos. 2009;30:21\u201334.","journal-title":"I. Adrenalectomized Rats. Biopharm Drug Dispos"},{"key":"549_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ijpharm.2014.02.003","volume":"465","author":"L Li","year":"2014","unstructured":"Li L, Song F, Tu M, Wang K, Zhao L, Wu X, et al. In vitro interaction of clopidogrel and its hydrolysate with OCT1, OCT2 and OAT1. Int J Pharm. 2014;465:5\u201310.","journal-title":"Int J Pharm"},{"key":"549_CR26","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/clinids\/7.5.625","volume":"7","author":"M Sands","year":"1985","unstructured":"Sands M, Kron MA, Brown RB. Pentamidine: a review. Rev Infect Dis. 1985;7:625\u201334.","journal-title":"Rev Infect Dis"},{"key":"549_CR27","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1124\/dmd.108.024083","volume":"37","author":"X Ming","year":"2009","unstructured":"Ming X, Ju W, Wu H, Tidwell RR, Hall JE, Thakker DR. Transport of dicationic drugs pentamidine and furamidine by human organic cation transporters. Drug Metab Dispos. 2009;37:424\u201330.","journal-title":"Drug Metab Dispos"},{"key":"549_CR28","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/infdis\/154.6.923","volume":"154","author":"JE Conte Jr","year":"1986","unstructured":"Conte JE Jr, Upton RA, Phelps RT, Wofsy CB, Zurlinden E, Lin ET. Use of a specific and sensitive assay to determine pentamidine pharmacokinetics in patients with AIDS. J Infect Dis. 1986;154:923\u201329.","journal-title":"J Infect Dis"},{"key":"549_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrd3028","volume":"9","author":"KM Giacomini","year":"2010","unstructured":"International Transporter Consortium, Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, et al. Membrane transporters in drug development. Nat Rev Drug Discov. 2010;9:215\u201336.","journal-title":"Nat Rev Drug Discov"},{"key":"549_CR30","doi-asserted-by":"publisher","first-page":"100096","DOI":"10.1016\/j.medidd.2021.100096","volume":"11","author":"S Fu","year":"2021","unstructured":"Fu S, Yu F, Sun T, Hu Z. Transporter-mediated drug-drug interactions - study design, data analysis, and implications for in vitro evaluations. Med Drug Discov. 2021;11:100096.","journal-title":"Med Drug Discov"},{"key":"549_CR31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejphar.2012.07.043","volume":"693","author":"T Arino","year":"2012","unstructured":"Arino T, Karakawa S, Ishiwata Y, Nagata M, Yasuhara M. Effect of cimetidine on pentamidine induced hyperglycemia in rats. Eur J Pharmacol. 2012;693:72\u201379.","journal-title":"Eur J Pharmacol"},{"key":"549_CR32","doi-asserted-by":"crossref","unstructured":"Bigagli E, Angelini J, Mugelli A, Rocca B. Oral P2Y(12) inhibitors: victims or perpetrators? A focused review on pharmacokinetic, clinically relevant drug interactions. Eur Cardiol. 2025;20:e17.","DOI":"10.15420\/ecr.2025.12"},{"key":"549_CR33","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4103\/0971-6866.92094","volume":"17","author":"G Umamaheswaran","year":"2011","unstructured":"Umamaheswaran G, Praveen RG, Arunkumar AS, Das AK, Shewade DG, Adithan C. Genetic analysis of OCT1 gene polymorphisms in an Indian population. Indian J Hum Genet. 2011;17:164\u201368.","journal-title":"Indian J Hum Genet"}],"container-title":["Journal of Pharmaceutical Health Care and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40780-026-00549-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-026-00549-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-026-00549-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:43:49Z","timestamp":1781631829000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40780-026-00549-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["549"],"URL":"https:\/\/doi.org\/10.1186\/s40780-026-00549-3","relation":{},"ISSN":["2055-0294"],"issn-type":[{"value":"2055-0294","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The case report was approved by the Ethics Committee of Saiseikai Futsukaichi Hospital (approval no. 451) for the off-label use of isCGM.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This report was prepared in accordance with the CARE (CAse REports) guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with reporting guidelines"}},{"value":"Written informed consent was obtained from the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}